ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist
(group practice)

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,962Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 823

$1.83M Total Retail Price of All Prescriptions

Rank: 7 out of 823

596 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 596 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

4% of this provider’s 10,400 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

42% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$131 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
NEXIUM 496 347 1 10
CRESTOR 376 289 2 20
FUROSEMIDE 326 285 3 7
LEVOTHYROXINE SODIUM 315 259 4 6
HYDROCODONE-ACETAMINOPHEN 285 117 S3 5 1
ATORVASTATIN CALCIUM 281 220 6 13
NAPROXEN 270 202 7 93
METFORMIN HCL 247 175 8 14
AZITHROMYCIN 235 158 9 48
AMLODIPINE BESYLATE 231 167 10 3
LOSARTAN POTASSIUM 215 170 11 26
SIMVASTATIN 213 181 12 2
POTASSIUM CHLORIDE 203 169 13 22
GLYBURIDE-METFORMIN HCL 202 144 R 14 121
JANUVIA 197 176 15 70
TRAMADOL HCL 197 125 15 15
METOPROLOL SUCCINATE 195 142 17 9
ZOLPIDEM TARTRATE 193 112 18 17
LOVAZA 186 149 19 117
DIOVAN 184 161 20 35
CYCLOBENZAPRINE HCL 180 102 R 21 63
OMEPRAZOLE 166 128 22 5
CIPROFLOXACIN HCL 163 128 23 32
JANUMET 156 116 24 193
VOLTAREN 154 131 25 187
SINGULAIR 151 112 26 120
NAMENDA 151 141 26 28
METOPROLOL TARTRATE 148 104 28 11
DONEPEZIL HCL 146 124 29 24
INSULIN SYRINGE 140 94 30 125
ACTOS 135 99 31 130
CELEBREX 130 117 32 115
LYRICA 129 62 33 58
TAMSULOSIN HCL 127 123 34 21
LISINOPRIL 125 89 35 4
MECLIZINE HCL 117 87 36 184
CILOSTAZOL 116 116 37 146
ALENDRONATE SODIUM 112 93 38 42
LOSARTAN-HYDROCHLOROTHIAZIDE 109 93 39 57
NOVOLOG MIX 70-30 106 63 40 214
DIOVAN HCT 106 98 40 79
LIPITOR 97 85 42 128
MELOXICAM 95 75 43 27
BENICAR 94 75 44 232
LANTUS 93 74 45 76
CYMBALTA 91 74 46 40
PRANDIN 90 71 47 341
LEVOFLOXACIN 88 72 48 101
MUPIROCIN 86 60 49 218
CLOPIDOGREL 85 72 50 16
CLONIDINE HCL 85 50 50 41
BYSTOLIC 82 59 52 98
POLYETHYLENE GLYCOL 3350 77 57 53 87
PLAVIX 73 59 54 25
CLOTRIMAZOLE-BETAMETHASONE 73 65 54 328
NASONEX 72 44 56 176
MONTELUKAST SODIUM 72 54 56 192
PEN NEEDLE 71 53 58 96
EVISTA 70 67 59 212
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 52 60 91
GABAPENTIN 68 50 60 8
LEVEMIR FLEXPEN 67 42 62 221
AZOR 66 60 63 392
AMOX TR-POTASSIUM CLAVULANATE 65 51 64 238
LEVEMIR 65 45 64 270
WARFARIN SODIUM 63 42 66 18
PANTOPRAZOLE SODIUM 63 48 66 30
HYDROCHLOROTHIAZIDE 62 39 68 29
CLINDAMYCIN HCL 60 37 69 297
VESICARE 59 36 70 126
NOVOLOG MIX 70-30 FLEXPEN 56 39 71 222
DICYCLOMINE HCL 56 40 71 145
ZETIA 56 52 71 100
AVODART 56 56 71 167
PRAVASTATIN SODIUM 55 47 75 23
IBUPROFEN 53 29 76 103
GLIMEPIRIDE 53 37 76 51
DEXILANT 52 45 78 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.